Organization
Yokohama, Japan
2 abstracts
Abstract
Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis.Org: National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, Disaster Medical Center, Tokyo, Japan, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
A low molecular weight baff signallinginhibitor, bik-13, ameliorates b cell activation in vitro and in vivo autoimmune models and consequently suppresses production of igg and cytokinesOrg: Keio University School of Medicine, Tokyo Research Unit, Immunology and Inflammation, Mitsubishi Tanabe Pharma, Yokohama, Japan,